This was one of the promises of candidate Macron in 2022. Making France a player in the world of medical research, particularly in biomedicine, this aspect of pharmaceutical innovation is set to explode in the coming years. Even in October, the quantitative goal was announced. Produce at least 20 of these treatments derived from living organisms (as opposed to a chemical pharmacopoeia) by 2030, up from 8 by 2020. On Tuesday, traveling to the Curie Institute in St. Cloud. Center of excellence in oncology, Emmanuel Macron has revealed the structures through which he hopes to create a virtuous synergy between universities, hospitals and companies that can make France catch up with the delays in this field.
“France has achieved great success”the president recalled, but “We have allowed weaknesses to emerge, inherited from several years of underinvestment, sometimes fragmentation, and as we have also left the competition…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.